Page last updated: 2024-10-30

letrozole and Headache

letrozole has been researched along with Headache in 4 studies

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"The aim of this survey was to compare the effect of letrozole with medroxyprogesterone acetate (MPA) in treatment of simple endometrial hyperplasia to preserve fertility in young women."9.17Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women. ( Dehghani, A; Dehghani-Tafti, M; Karimi Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S, 2013)
"To present the basis of the decision of the Food and Drug Administration to grant accelerated approval for letrozole for extended adjuvant treatment of early-stage breast cancer in postmenopausal women after completion of adjuvant tamoxifen."7.73Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen. ( Johnson, JR; Kelly, R; Mann, BS; Pazdur, R; Sridhara, R; Williams, G, 2005)
"The aim of this survey was to compare the effect of letrozole with medroxyprogesterone acetate (MPA) in treatment of simple endometrial hyperplasia to preserve fertility in young women."5.17Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women. ( Dehghani, A; Dehghani-Tafti, M; Karimi Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S, 2013)
"To present the basis of the decision of the Food and Drug Administration to grant accelerated approval for letrozole for extended adjuvant treatment of early-stage breast cancer in postmenopausal women after completion of adjuvant tamoxifen."3.73Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen. ( Johnson, JR; Kelly, R; Mann, BS; Pazdur, R; Sridhara, R; Williams, G, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tabatabaie, A1
Karimi Zarchi, M1
Dehghani-Tafti, M1
Miratashi-Yazdi, A1
Teimoori, S1
Dehghani, A1
Mann, BS1
Johnson, JR1
Kelly, R1
Sridhara, R1
Williams, G1
Pazdur, R1
Trunet, PF1
Mueller, P1
Bhatnagar, AS1
Dickes, I1
Monnet, G1
White, G1
Buzdar, A1
Howell, A1

Reviews

1 review available for letrozole and Headache

ArticleYear
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

    Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibit

2001

Trials

2 trials available for letrozole and Headache

ArticleYear
Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Curettage; Dizziness; Endometrial Hyperplasia; Estra

2013
Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:2

    Topics: Administration, Oral; Adult; Aldosterone; Aromatase Inhibitors; Blood Pressure; Dose-Response Relati

1993

Other Studies

1 other study available for letrozole and Headache

ArticleYear
Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Br

2005